Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/21106
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
- IOC - Artigos de Periódicos [12481]
Metadatos
Mostrar el registro completo del ítem
A MULTICENTRE RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF SINGLE-DOSE PRAZIQUANTEL AT 40 MG/KG VS. 60 MG/KG FOR TREATING INTESTINAL SCHISTOSOMIASIS IN THE PHILIPPINES, MAURITANIA, TANZANIA AND BRAZIL
Autor
Afiliación
UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR). World Health Organization, Geneva, Switzerland.
Methodology and Statistical Unit, Center for Health Studies. Centre de Recherche – Sante´ . Strassen, Luxembourg.
National Institutes of Health. University of the Philippines Malaria. Manila, Philippines.
National Institute for Medical Research. Mwanza Medical Research Centre. Mwanza, Tanzania.
Nutrition et Actes Médicaux. Institut National de Recherches en Santé Publique (INRSP). Nouakchott, Mauritania.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Eco-Epidemiologia e Controle da Esquistossomose e Geohelmintoses. Rio de Janeiro, RJ. Brasil.
University of the Philippines. College of Medecine. Department of Clinical Epidemiology. Manilla, Philippines.
National Institute for Medical Research. Mwanza Medical Research Centre. Mwanza, Tanzania.
Ministére de la Santé /P.E.V.. Nouakchott, Mauritania.
Universidade Federal de Pernambuco. Centro de Ciências da Saúde. Departamento de Medicina Clínica. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Eco-Epidemiologia e Controle da Esquistossomose e Geohelmintoses. Rio de Janeiro, RJ. Brasil.
UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR). World Health Organization, Geneva, Switzerland.
Latin America Regional Office, Drugs for Neglected Diseases Initiative. Rio de Janeiro, RJ, Brasil.
Methodology and Statistical Unit, Center for Health Studies. Centre de Recherche – Sante´ . Strassen, Luxembourg.
National Institutes of Health. University of the Philippines Malaria. Manila, Philippines.
National Institute for Medical Research. Mwanza Medical Research Centre. Mwanza, Tanzania.
Nutrition et Actes Médicaux. Institut National de Recherches en Santé Publique (INRSP). Nouakchott, Mauritania.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Eco-Epidemiologia e Controle da Esquistossomose e Geohelmintoses. Rio de Janeiro, RJ. Brasil.
University of the Philippines. College of Medecine. Department of Clinical Epidemiology. Manilla, Philippines.
National Institute for Medical Research. Mwanza Medical Research Centre. Mwanza, Tanzania.
Ministére de la Santé /P.E.V.. Nouakchott, Mauritania.
Universidade Federal de Pernambuco. Centro de Ciências da Saúde. Departamento de Medicina Clínica. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Eco-Epidemiologia e Controle da Esquistossomose e Geohelmintoses. Rio de Janeiro, RJ. Brasil.
UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR). World Health Organization, Geneva, Switzerland.
Latin America Regional Office, Drugs for Neglected Diseases Initiative. Rio de Janeiro, RJ, Brasil.
Resumen en ingles
Praziquantel at 40 mg/kg in a single dose is the WHO recommended treatment for all forms of schistosomiasis, but 60 mg/kg is also deployed nationally.
Compartir